He Zhipeng, Chen Meiling, Huang Yiping, Chen Lili, Wang Bixin, Wang Huixian, Yang Mengting, Xiao Xueting, Lu Yanhong, Chen Jiaying, Wu Yong
Department of Hematology, Union Hospital, Fujian Medical University, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fuzhou, China.
Medicine (Baltimore). 2019 Mar;98(13):e14998. doi: 10.1097/MD.0000000000014998.
Acute myeloid leukemia (AML) is a malignantly clonal and highly heterogeneous disease. Although the treatment of AML has brought promising outcomes for younger patients, prognosis of the elderly remains dismal. Innovative regimens are increasingly necessary to be investigated.
We present an 86-year-old AML patient with fever, cough, and sputum production.
A diagnosis of AML with maturation (AML-M2) and AML1/ETO was made.
The patient was treated with a regimen of Homoharringtonine coupled with arsenic trioxide.
The AML-M2 patient with AML1/ETO achieved incomplete remission, but showed few toxic side effects and improved survival. Besides, we analyzed the dynamic counts of complete blood cells during the treatment. The count of white blood cell had a positive correlation with the percentage of blast cells (r = 0.65), both of which had a negative correlation with the percentage of segmented neutrophils (r = -0.63, -0.89).
Homoharringtonine and arsenic trioxide may induce both the apoptosis and differentiation of leukemic cells in AML-M2 with AML1/ETO.
急性髓系白血病(AML)是一种恶性克隆且高度异质性的疾病。尽管AML的治疗给年轻患者带来了有希望的结果,但老年患者的预后仍然不佳。越来越有必要研究创新的治疗方案。
我们报告一名86岁的AML患者,伴有发热、咳嗽和咳痰。
诊断为伴有成熟型的AML(AML-M2)及AML1/ETO。
该患者接受高三尖杉酯碱联合三氧化二砷的治疗方案。
该AML-M2伴AML1/ETO患者达到不完全缓解,但显示出很少的毒副作用且生存期延长。此外,我们分析了治疗期间全血细胞的动态计数。白细胞计数与原始细胞百分比呈正相关(r = 0.65),二者均与分叶核中性粒细胞百分比呈负相关(r = -0.63,-0.89)。
高三尖杉酯碱和三氧化二砷可能诱导伴有AML1/ETO的AML-M2白血病细胞凋亡和分化。